In this retrospective study, we analyzed the efficacy of PSMA-PET/CT in detecting recurrent OMD, looked for predictive factors, and evaluated the impact of PSMA-PET/CT findings on clinical management. This evidence concerns the gene FOLH1 and occult macular dystrophy.